| Literature DB >> 17067387 |
Carol Iversen1, Mike Waddington, Jim J Farmer, Stephen J Forsythe.
Abstract
BACKGROUND: Enterobacter sakazakii is an emergent pathogen that has been associated with neonatal infections through contaminated powdered infant milk formula. The species was defined by Farmer et al. (1980) who described 15 biogroups according to the biochemical characterization of 57 strains. This present study compares genotypes (DNA cluster groups based on partial 16S rDNA sequence analysis) with the biochemical traits for 189 E. sakazakii strains.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17067387 PMCID: PMC1634753 DOI: 10.1186/1471-2180-6-94
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Origins of E. sakazakii isolates used in this study.
| Biogroup | Strain origin | Total | ||||
| Clinical | Powdered infant formula and infant food | Other dried food products | Environmental | Unknown | ||
| 1 | 7 | 16 | 33 | 2 | 2 | 60 |
| 2 | 4 | 12 | 23 | 3 | 42 | |
| 3 | 4 | 1 | 1 | 6 | ||
| 4 | 4 | 1 | 1 | 3 | 9 | |
| 5 | 2 | 2 | 11 | 1 | 16 | |
| 6 | 1 | 1 | 2 | |||
| 7 | 2 | 1 | 1 | 4 | ||
| 8 | 1 | 2 | 2 | 2 | 7 | |
| 9 | 10 | 2 | 1 | 13 | ||
| 10 | 1 | 1 | ||||
| 11 | 1 | 1 | ||||
| 12 | 1 | 1 | ||||
| 13 | 3 | 3 | 1 | 7 | ||
| 14 | 1 | 2 | 2 | 5 | ||
| 15 | 1 | 3 | 2 | 6 | ||
| 16 | 1 | 7 | 1 | 9 | ||
| Total | 42 | 38 | 89 | 3 | 17 | 189 |
Assignment of strains to the biogroups originally defined by Farmer et al. [1]
| Farmer Biogroup | Additional group | Phenotypea | No. of strains | 16s rDNA cluster | |||||||||
| VP | MR | Nit | Orn | Mot | Ino | Dul | Ind | Malo | Gas | ||||
| 1 | + | - | + | + | + | + | - | - | - | + | 60 | 1 | |
| 2 | + | - | + | + | + | - | - | - | - | + | 38 | 1 | |
| 2a | + | - | + | + | - | - | - | - | - | + | 4 | 1 | |
| 3 | + | - | + | + | - | + | - | - | - | + | 6 | 1 | |
| 4 | + | - | + | - | + | + | - | - | - | + | 6 | 1 | |
| 4a | + | - | + | - | - | + | - | - | - | + | 3 | 1 | |
| 5 | + | - | + | + | + | + | - | - | + | + | 10 | 1 | |
| 5a | + | - | + | + | - | + | - | - | + | + | 6 | 1 | |
| 6 | + | - | + | + | + | + | - | + | - | + | 2 | 4 | |
| 7 | + | - | + | + | + | + | - | - | - | - | 4 | 1 | |
| 8 | + | - | - | + | + | + | - | - | - | + | 0 | 1 | |
| 8a | + | - | - | + | + | - | - | - | - | + | 3 | 1 | |
| 8b | + | - | - | + | + | + | - | - | + | + | 2 | 1 | |
| 8c | + | - | - | + | + | - | - | - | + | + | 2 | 1 | |
| 9 | + | - | + | + | + | - | - | - | + | + | 12 | 1 | |
| 9a | - | - | + | + | + | - | - | - | + | + | 1 | 1 | |
| 10 | + | - | + | + | + | - | - | + | - | + | 1 | 4 | |
| 11 | + | - | + | + | + | - | + | - | - | + | 1 | 1 | |
| 12 | + | - | + | + | + | + | - | + | + | + | 1 | 4 | |
| 13 | - | + | + | + | + | + | - | - | - | + | 2 | 1 | |
| 13a | - | + | + | + | - | + | - | - | - | + | 3 | 1 | |
| 13b | - | + | + | - | + | + | - | - | - | + | 1 | 1 | |
| 13c | - | - | + | + | + | + | - | - | - | + | 1 | 1 | |
| 14 | + | - | + | - | + | - | - | - | + | + | 4 | 1 | |
| 14a | + | - | + | - | + | - | - | - | - | + | 1 | 1 | |
| 15 | + | - | + | + | + | + | + | + | + | + | 6 | 3 | |
| New Biogroup | 16 | + | - | + | + | + | + | + | - | + | + | 6 | 2 |
| 16a | + | - | + | + | - | + | + | - | + | + | 1 | 2 | |
| 16b | + | - | + | + | + | + | + | - | - | + | 1 | 2 | |
| 16c | + | - | + | - | - | + | + | - | + | + | 1 | 2 | |
aVP, Voges-Proskauer; MR, methyl red; Nit, nitrate reduction; Orn, ornithine utilization; Mot, motility at 37°C; Ino, acid production from inositol; Dul, acid production from dulcitol; Ind, indole production; Malo, malonate utilization; Gas, gas production from glucose. All isolates positively reacted with α-methyl-D-glu, with the exception of biogroup 15 isolates.
Figure 1Maximum parsimony tree (unrooted) showing the four genomic clusters of . Gaps were not considered an extra state, and the topology was optimised using simulated annealing.
Biochemical differentiation of E. sakazakii 16S rDNA clusters.
| Farmer Biogroup | Phenotype a | No. of strains | Genomic cluster | ||
| Ino | Dul | Ind | |||
| 1–5, 7–9, 13, 14 | (+/-) | - | - | 169 | 1 |
| 11 | - | + | - | 1 | 1 |
| 16 | + | + | - | 9 | 2 |
| 15 | + | + | + | 6 | 3 |
| 6, 10, 12 | (+/-) | - | + | 4 | 4 |
aIno, acid production from inositol; Dul, acid production from dulcitol; Ind, indole production; (+/-), some stains positive, some strains negative, the test is used to define subgroups.
Representative strains from each of the biogroups used in this study.
| Biogroup | NTUa strain number | Source | Origin |
| 1 | 1 | NCTC 11467b | Child's throat (Type strain) (ATCC 29544 = CDC 4562-70) |
| 2 | 12 | Cèské Budéjovicec | Faeces (adult 3753) |
| 2a | 512 | Radboudd | Clinical (Prague 26248) |
| 3 | 680 | CDC 996-77e | Spinal fluid (New York, USA) |
| 4 | 683 | CDC 407-77 | Sputum (Pennsylvania, USA) |
| 4a | 515 | Radboud | Clinical (Prague 26706) |
| 5 | 685 | CDC 1716-77 | Blood (Connecticut, USA) |
| 5a | 472 | NTU | Infant formula (Korea) |
| 6 | 564 | CDC 5960-70 | Blood (Florida, USA) |
| 7 | 686 | CDC 9369-75 | Unknown |
| 8a | 22 | FSM E321f | Infant formula (France) |
| 8b | 15 | Cèské Budéjovice | Faeces (adult 2422) |
| 8c | 35 | NTU | Infant cereal (Washington, USA) |
| 9 | 681 | CDC 1058-77 | Breast abscess |
| 9a | 521 | Radboud | Clinical (Prague 27288) |
| 10 | 582 | NCTC 9844 | Unknown |
| 11 | 684 | CDC 3128-77 | Sputum (Alabama, USA) |
| 12 | 563 | CDC 0743-75 | Foot wound (Wisconsin, USA) |
| 13 | 567 | CDC 9363-75 | Unknown |
| 13a | 535 | Radboud | Milk powder (New Zealand) |
| 13b | 507 | Radboud | Clinical (Prague 25569) |
| 13c | 101 | NTU | Whole mixed spice |
| 14 | 565 | CDC 1895-73 | Faeces (Maryland, USA) |
| 14a | 33 | NTU | Baby rice (Herndon, USA) |
| 15 | 566 | CDC 3523-75 | Bone marrow (Arizona, USA) |
| 16 | 9 | NTU | Infant food (cheese puffs) |
| 16a | 92 | NTU | Herb (biota tops) |
| 16b | 57 | NTU | Milk powder (UK) |
| 16c | 581 | NCTC 9529 | Water |
aNottingham Trent University, Nottingham, UK; bNCTC, London, UK; cHospital Cèské Budéjovice, Czech Republic; dDepartment of Medical Microbiology, Radboud, Nijmegen, Netherlands; eCDC, Atlanta, GA, USA; fNestlé Research Center, Lausanne, Switzerland.